sever
acut
respiratori
syndrom
sar
seriou
lifethreaten
strikingli
mortal
respiratori
ill
caus
sarscov
sarscov
contain
chymotrypsinlik
main
proteas
analog
main
picornaviru
proteas
pro
pro
play
pivot
role
viral
replic
cycl
potenti
target
sar
inhibitor
develop
seri
isatin
deriv
possibl
sarscov
pro
inhibitor
design
synthes
evalu
vitro
proteas
assay
use
fluorogen
substrat
peptid
sever
show
potent
inhibit
pro
structureact
relationship
analyz
possibl
bind
interact
mode
propos
molecular
dock
studi
among
compound
show
potent
inhibitori
activ
pro
ic
lm
result
indic
inhibitor
could
potenti
develop
antisar
drug
sever
acut
respiratori
syndrom
sar
seriou
lifethreaten
upper
respiratori
tract
diseas
common
symptom
cough
high
fever
headach
rigor
myalgia
dizzi
sar
abruptli
emerg
spread
wide
becom
epidem
serious
affect
public
health
economi
mani
countri
although
sar
control
known
sar
transmiss
record
anywher
world
mutant
characterist
coronaviru
caus
agent
sar
indic
possibl
reemerg
emerg
novel
human
coronaviru
emc
hcovemc
middl
east
sinc
april
far
led
case
human
infect
fatal
march
sar
viru
novel
human
coronaviru
featur
largest
positivestrand
rna
genom
known
date
kb
also
term
sarscov
cov
encod
chymotrypsinlik
proteas
pro
play
pivot
role
viru
replic
cystein
proteas
pro
fuction
analog
main
picornavirida
proteas
pro
catalyt
dyad
activ
site
pro
cleav
replicas
polyprotein
conserv
site
canon
leugln
ser
ala
gli
sequenc
posit
wellconserv
gln
residu
posit
hydrophob
amino
acid
residu
given
essenti
role
viral
process
sarscov
pro
consid
attract
target
antisar
coronaviru
infect
larg
number
peptidomimet
smallmolecul
inhibitor
pro
report
date
includ
peptideomimet
stilben
deriv
hydroxyferroquin
deriv
natur
product
keton
glycyrrhiz
acid
pyrimidin
bunsatur
ester
pyrazolon
nucleosid
analog
isatin
deriv
although
mani
candid
antisar
cov
agent
identifi
effect
therapeut
drug
vaccin
develop
far
highthroughput
screen
reveal
potent
inhibitor
also
soak
crystal
pro
recent
obtain
laboratori
fig
although
complex
deposit
protein
data
bank
poor
structur
qualiti
fact
provid
us
import
clue
isatin
deriv
inhibitori
activ
pro
previous
chen
zhou
et
al
report
new
class
potent
smallmolecul
isatinbas
pro
inhibitor
fig
conclud
posit
favor
carboxamid
group
posit
favor
larg
hydrophob
substitu
letter
investig
replac
carboxamid
group
use
seri
substitut
sulfonamid
group
isatin
believ
modif
improv
inhibitori
activ
sar
cov
pro
also
carri
molecular
dock
studi
obtain
potenti
bind
mode
inhibitor
compound
obtain
commerci
supplier
synthesi
isatin
deriv
summar
scheme
intermedi
prepar
sandmey
reaction
substitut
anilin
hydroxylamin
hydrochlorid
chloral
hydrat
result
hydroxyiminoacetanilid
intermedi
cycliz
heat
concentr
sulfur
acid
give
correspond
isatin
deriv
respect
seri
compound
prepar
isatin
follow
literatur
method
scheme
typic
procedur
isatin
sulfon
presenc
chlorosulfon
acid
howev
contrast
previous
publish
result
gemdichloroisatin
isatin
isol
yield
ratio
moreov
desir
sulfonyl
chlorid
product
obtain
interestingli
react
secondari
amin
respect
especi
directli
produc
compound
high
yield
paper
mixtur
compound
isol
appli
synthes
target
compound
gemdichloro
moieti
intermedi
subject
acid
hydrolysi
afford
alkyl
achiev
presenc
variou
bromid
iodid
nah
dmf
analyt
spectral
data
target
compound
accord
structur
seri
compound
substitut
benzen
ring
isatin
initi
screen
sar
cov
pro
vitro
result
summar
tabl
sar
cov
pro
found
sensit
substitu
posit
inhibitori
activ
result
show
compound
substitut
superior
compound
substitut
posit
result
indic
modif
isatin
ring
suitabl
much
effect
increas
inhibitori
potenc
replac
bromin
iodin
chlorin
fluorin
increas
inhibitori
activ
tabl
show
compound
contain
oxi
substitu
display
high
inhibitori
activ
except
result
reveal
substitu
contain
oxi
group
import
improv
inhibitori
activ
consid
inhibitori
tendenc
tabl
isatin
deriv
prepar
evalu
inhibit
assay
result
shown
tabl
compar
compound
exhibit
higher
inhibit
ratio
ic
lm
although
compound
less
activ
exhibit
increas
inhibitori
potenc
one
carbon
ic
lm
ic
lm
two
carbon
ic
lm
aromat
ring
piperazin
show
similar
profil
approxim
twofold
higher
potenc
compound
contain
hydrophil
moieti
pyridinyl
instead
phenyl
ring
slightli
increas
activ
ic
lm
compar
compound
particular
substitu
flexibl
increas
potenc
ic
lm
compar
result
suggest
steric
effect
isatin
scaffold
crucial
ensur
inhibitori
potenc
replac
piperazinyl
moieti
simpl
cyclic
secondari
amin
also
examin
tabl
determin
suitabl
substitu
unexpectedli
induc
appar
improv
inhibitori
potenc
bicycl
substitu
isatin
deriv
show
better
potenc
ic
lm
among
ic
lm
ic
lm
optim
substitu
enzym
inhibit
enhanc
potenc
compar
respect
determin
influenc
substitu
synthes
examin
seri
nsubstitut
isatin
deriv
determin
whether
inhibitori
potenc
sar
cov
pro
enhanc
modifi
isatin
deriv
posit
shown
tabl
introduct
methyl
benzyl
bnaphthyl
methyl
posit
show
signific
activ
variat
remark
methyl
posit
result
enhanc
inhibitori
potenc
compar
parent
compound
tabl
compound
display
higher
potenc
one
benzyl
bnaphthyl
methyl
howev
ic
lm
sensit
methyl
ic
lm
benzyl
ic
lm
exhibit
high
inhibitori
potenc
explain
similar
activ
tendenc
difficult
dock
studi
conduct
predict
bind
mode
isatin
onto
activ
site
sar
cov
pro
pdb
code
use
glide
glide
model
schroding
softwar
compound
dock
activ
site
shown
figur
compound
hydrogen
bond
proteas
gener
hydrogen
bond
notabl
carbonyl
group
nitrogen
atom
isatin
import
format
hydrogen
bond
meanwhil
model
shown
figur
reveal
isatin
scaffold
dock
site
side
chain
r
r
locat
site
sar
cov
pro
respect
model
compound
sarscov
pro
present
differ
previous
report
isatin
deriv
orient
isatin
core
flip
fig
substitut
enabl
compound
fit
hydrophob
site
dock
result
furthermor
simpl
sixmemb
ring
sulfonyl
group
isatin
well
fit
demonstr
potent
inhibit
howev
isatin
deriv
modifi
rigid
bicycl
substitu
fit
limit
space
led
diminish
inhibitori
activ
interestingli
increas
length
substitut
enabl
compound
contain
flexibl
group
extend
site
mention
previou
refer
dock
experi
support
observ
enzymat
assay
potenc
deriv
follow
order
lm
lm
lm
regard
substitu
posit
group
replac
substitut
methyl
benzyl
substitut
less
accommod
hydrophob
characterist
site
addit
molecul
total
score
predict
show
analog
bind
affin
rel
total
score
consist
experiment
result
base
find
believ
activ
titl
compound
improv
modifi
simpl
sixmemb
ring
substitut
posit
methyl
group
lead
better
combin
compound
protein
pocket
deriv
result
discoveri
compound
power
potenc
ic
lm
result
current
studi
suggest
isatin
deriv
similar
inhibitori
activ
report
isatin
meanwhil
comput
model
associ
complex
titl
compound
proteas
ration
inhibitori
activ
appar
isatin
modifi
simpl
sixmemb
ring
bulki
substitu
suffici
flexibl
coupl
methyl
posit
could
dramat
promot
inhibitori
activ
addit
similar
orient
isatin
core
found
dock
sock
studi
result
could
serv
import
basi
structur
optim
reaction
carri
n
atmospher
unless
otherwis
note
commerci
reagent
highest
puriti
avail
tetrahydrofuran
thf
distil
sodium
benzophenon
analyt
tlc
perform
shanghai
sanpont
column
chromatographi
carri
shanghai
sanpont
gel
mesh
nmr
spectra
record
bruker
nmr
spectra
record
cdcl
dmso
room
temperatur
chemic
shift
h
c
spectra
quot
ppm
downfield
tm
coupl
constant
refer
j
valu
esi
mass
spectra
obtain
use
bruker
esquirelctm
esi
ion
trap
spectromet
ftir
spectra
determin
room
temperatur
within
cm
perkinelm
spectrum
ftir
spectromet
use
kbr
pellet
melt
point
determin
use
digit
melt
point
apparatu
element
analysi
carbon
hydrogen
nitrogen
obtain
elementar
vario
micro
cube
element
analys
gener
procedur
synthesi
compound
chloral
hydrat
g
mmol
ad
ml
water
dissolv
sodium
sulfat
g
mol
temperatur
reach
appropri
anilin
mmol
ml
aqueou
hydrochlor
acid
ad
dropwis
reaction
mixtur
stir
h
suspens
hydroxylamin
hydrochlorid
g
mol
rapidli
ad
reaction
mixtur
mixtur
heat
h
stir
cool
room
temperatur
correspond
hydroxyiminoacetanilid
collect
filtrat
wash
water
dri
vacuum
nitrogen
atmospher
one
gram
intermedi
ad
small
portion
stir
ml
concentr
sulfur
acid
preheat
maintain
intermedi
ad
darkcolor
solut
heat
addit
min
cool
room
temperatur
pour
onto
ml
crush
ice
allow
stand
min
precipit
collect
filtrat
wash
water
three
time
dri
vacuum
yield
product
nitrogen
ice
bath
ml
mmol
chlorosulfon
acid
ad
dropwis
g
mmol
isatin
mixtur
heat
h
mixtur
cool
room
temperatur
care
pour
onto
g
ice
result
yellow
solid
filter
wash
cold
water
dissolv
ethyl
acet
dri
na
mixtur
purifi
column
chromatographi
petroleum
ether
ethylacet
compound
g
mg
obtain
interestingli
either
react
secondari
amin
directli
produc
compound
high
yield
result
precipit
use
next
step
without
separ
pale
yellow
powder
nitrogen
atmospher
mixtur
mmol
dissolv
ml
dri
thf
solut
secondari
amin
mmol
diisopropylethylamin
mmol
ml
thf
slowli
ad
stir
reaction
mixtur
room
temperatur
overninght
solvent
remov
brown
oil
obtain
crude
product
ad
ml
vv
acet
acidwat
solut
mixtur
heat
overnight
g
nahco
care
ad
mixtur
cool
product
extract
ethylacet
wash
water
dri
mgso
target
compound
purifi
column
chromatographi
use
ch
cl
ch
oh
compound
prepar
accord
gener
procedur
use
pale
yellow
powder
yield
mp
compound
prepar
accord
gener
procedur
use
piperazin
pale
yellow
powder
yield
mp
compound
prepar
accord
gener
procedur
use
piperazin
pale
yellow
powder
yield
mp
compound
prepar
accord
gener
procedur
use
piperazin
dihydrochlorid
neutral
hydrochlor
acid
piperazin
dihydrochlorid
diisopropylethylamin
compound
prepar
accord
gener
procedur
use
pale
yellow
powder
yield
mp
compound
prepar
accord
gener
procedur
use
compound
prepar
accord
gener
procedur
use
piperidin
yellow
powder
yield
mp
mg
nah
mmol
ad
solut
correspond
mmol
ml
dmf
mixtur
stir
min
mmol
r
x
ad
mixtur
stir
h
room
temperatur
ad
ml
water
extract
ml
ethyl
acet
wash
ml
satur
nacl
dri
na
solvent
remov
crude
product
purifi
column
chromatographi
ch
cl
afford
product
compound
prepar
accord
gener
procedur
use
compound
iodomethan
yellow
powder
yield
mp
compound
prepar
accord
gener
procedur
use
compound
bromomethyl
naphthalen
yellow
powder
yield
mp
compound
prepar
accord
gener
procedur
use
compound
benzyl
bromid
yellow
powder
yield
mp
sequenc
sarscov
pro
clone
vector
transform
escherichia
coli
cell
recombin
protein
gsttag
purifi
gstglutathion
affin
chromatographi
ionexchang
column
chromatographi
result
purifi
protein
high
puriti
judg
sdspage
analysi
concentr
lm
buffer
contain
mm
trishcl
ph
mm
edta
substrat
synthes
shanghai
biolog
engin
compani
dissolv
dmso
mm
liquid
storag
use
sar
cov
pro
inhibit
assay
conduct
fluoresc
reson
energi
transfer
fret
natur
substrat
amino
acid
sequenc
avlqsgfrkk
sarscov
pro
start
mca
fluoresc
group
connect
dnp
fluoresc
quench
group
penultim
k
screen
system
follow
tabl
final
concentr
sarscov
pro
substrat
compound
lm
lm
mm
respect
settl
concentr
protein
compound
preheated
oscil
substrat
ad
mixtur
excitationemiss
light
nm
test
carri
everi
time
draw
curv
maximum
valu
neg
control
curv
slope
v
largest
compound
curv
slope
v
inhibit
ratio
defin
v
ic
valu
obtain
equat
v
v
ic
v
initi
rate
reaction
without
inhibitor
v
initi
rate
reaction
inhibitor
variou
concentr
inhibitor
concentr
crystal
transfer
cryoprotect
solut
consist
crystal
buffer
vv
glycol
vv
glycerol
crystallograph
data
routin
collect
convent
inhous
rigaku
xray
gener
raxi
detector
wavelength
data
process
reduc
packag
total
frame
collect
angl
exposur
time
sframe
strategi
result
complet
vast
major
data
set
reduc
r
factor
data
process
scale
scalepack
phase
map
calcul
perform
use
phaser
model
electrondens
fit
softwar
coot
use
manipul
model
structur
compound
geometri
built
maestro
clean
perform
short
forcefield
minim
compound
subject
full
geometri
optim
dft
level
use
gaussian
glide
glide
model
schroding
softwar
use
perform
dock
simul
fulli
optim
xray
structur
sar
coronaviru
pro
pdb
id
use
initi
protein
model
dock
protein
structur
prepar
use
suit
protein
prepar
wizard
chaina
dimer
use
simul
water
molecul
delet
protein
structur
dock
standard
precis
glidescor
score
function
use
rank
bind
pose
